Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Reexamination Certificate
2005-07-06
2008-09-30
Witherspoon, Sikarl A (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
C560S106000, C560S110000, C514S561000, C514S563000
Reexamination Certificate
active
07429673
ABSTRACT:
The compounds of the general formula (I) in which X is represents two hydrogen atoms, a π-bond, oxygen or methylene: R2 is a C6-C12aryl, or arylalkyl residue: R3 is hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies mediated by vanilloid receptors type I.
REFERENCES:
patent: 0 132 113 (1985-01-01), None
patent: 1 426 047 (2004-06-01), None
patent: WO 00/16756 (2000-03-01), None
Appendino, Giovanni et al: “N-Acylvanillamides: Development of an Expeditious Synthesis and Discovery of New Acyl Templates for Powerful Activation of the Vanilloid Receptor” Journal of Medicinal Chemistry, 45(17), 3739-3745 CODEN: JMCMAR; ISSN: 0022-2623, 2002, XP002346966 cited in the application p. 3742; compound 1Q, p. 3742, col. 1, last paragraph—p. 3742, col. 2, paragraph 1.
Janusz J M et al: “Vanilloids. 1. Analogs of Capsaicin With Antinociceptive and Antiinflammatory Activity” Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 36, No. 18, 1993, pp. 2595-2604, XP001008868 ISSN: 0022-2623 table III; compound 36.
Appendino, Giovanni et al: “Development of the first ultra-potent “capsaicinoid” agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential” Journal of Pharmacology and Experimental Therapeutics, 312(2), 561-570 CODEN: JPETAB; ISSN: 0022-3565, 2005, XP008053161, p. 566, col. 1, line 30-line 35 p. 566; table 1.
Appendino Giovanni
Di Marzo Vincenzo
Fontana Gabriele
Morazzoni Paolo
Riva Antonella
Indena S.p.A.
Witherspoon Sikarl A
Young & Thompson
LandOfFree
TRPV1 agonists, formulations containing them and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TRPV1 agonists, formulations containing them and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TRPV1 agonists, formulations containing them and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3981209